Thalomid, Thalidomide

Thalomid, Thalidomide Newswire

Comprehensive Real-Time News Feed for Thalomid, Thalidomide (generic).

Results 1 - 20 of 141 in Thalomid, Thalidomide (generic)

  1. Inside London's Wild Brixton AcademyBy Tom SykesRead the original story w/Photo

    Monday Sep 29 | The Daily Beast

    To turn the Brixton Academy into a success, Simon Parkes had to face down intimidating thugs-and make capital from Kurt Cobain's death. When I was in my early twenties, my friend Rupert got what we all considered to be the coolest job in the world, working at London's most exciting live music venue, the Brixton Academy.

    Comment?

  2. PharmacovigilanceRead the original story w/Photo

    Wednesday Sep 24 | Investopedia

    The process of detecting, evaluating and preventing negative side effects from medications. Pharmacovigilance aims to improve patient safety and quality of care.

    Comment?

  3. Wife of ex-Coutts banker spared jail for helping him launder money...Read the original story w/Photo

    Monday Sep 22 | Daily Mail

    Moment Robert F Kennedy Jr lost his cool and grabbed mic from reporter questioning him about his own carbon footprint ISIS urges Muslims to 'kill American disbelievers' and calls John Kerry an 'old uncircumcised geezer' in latest propaganda audio release Former Defense Secretary Leon Panetta says Obama helped ISIS grow by ignoring national security team's advice to arm Syrian rebels Warrant is issued for nursing assistant who was seen putting his arm around Hannah Graham on night she vanished as her parents make emotional TV appeal The agony of ecstasy: Man who has suffered 100 orgasms A DAY for past two years after slipping a disc in his back - but can't enjoy sex Man, 55, who served 23 years in prison for a murder he didn't commit dies from asthma attack - just days before he was set to start $124million lawsuit How common is YOUR birthday? Charts reveal most American babies are born ... (more)

    Comment?

  4. To Your Good Health: Discussion of the HPV vaccineRead the original story w/Photo

    Thursday Sep 18 | TwinCities

    Q: In a recent column, you strongly recommended the HPV vaccine for everyone ages 13 to 26. Last week, an article came out about the much lower rates of HPV vaccination as compared with the rates of other vaccinations recommended for teens. I was born in the 1960s, and grew up hearing about "perfectly safe" thalidomide, which later was found to cause birth defects years after it was given to pregnant women.

    Comment?

  5. Roach: A discussion of the HPV vaccineRoach: A discussion of the HPV...Read the original story w/Photo

    Tuesday Sep 16 | The Town Talk

    Roach: A discussion of the HPV vaccine Dear Dr. Roach: In a recent column, you strongly recommended the HPV vaccine for everyone ages 13 to 26. Check out this story on thetowntalk.com: Dr. Roach regrets that he is unable to answer individual letters, but will incorporate them in the column whenever possible. Readers may email questions to ToYourGoodHealth@med.cornell.edu or request an order form of available health newsletters at P.O. Box 536475, Orlando, FL 32853-6475.

    Comment?

  6. 'Fair City' cast, past and present, gather on set for 25th anniversary celebrationsRead the original story w/Photo

    Tuesday Sep 16 | Independent.ie

    From illicit affairs with local priests to cold-blooded murder to gay rights, Ireland's top soap has tackled the entire spectrum of issues facing Irish society over its 25 year run. Members of the Fair City cast, past and present, from Tom Jordan to Clelia Murphy, Aoibheann McCaul and George McMahon gathered on set today to raise a glass to Ireland's longest running soap.

    Comment?

  7. Air pollution risksRead the original story w/Photo

    Thursday Sep 11 | Thetelegraphand Argus

    Bradford Council are aware of my concern over the infant mortality issue following my FoI request for infant death rates at electoral ward level. Older readers seeing the birth defects article might remember the thalidomide scandal, when the link between that drug and terrible birth defects was initially denied by the medical establishment and the manufacturer.

    Comment?

  8. Phase III First MM-020/Ifm 07-01 trial of Revlimid lenalidomide plus...Read the original story

    Wednesday Sep 10 | Hispanic Business

    Initial findings, including that the trial had met its primary endpoint of progression free survival , were reported during the plenary session at the 55th , demonstrated that at a median follow-up of 37 months among surviving patients, the median progression-free survival was 25.5 months with continuous oral lenalidomide plus low-dose dexamethasone , 20.7 months with a fixed course of oral lenalidomide plus low-dose dexamethasone and 21.2 months with melphalan, prednisone and thalidomide . This resulted in a 28% reduction in risk of progression or death for patients treated with continuous Rd compared with those treated with MPT .

    Comment?

  9. Phase III First trial results of Revlimid Plus Dexamethasone in...Read the original story w/Photo

    Monday Sep 8 | Medical News Today

    Celgene Corporation has announced that data from FIRST - an open-label phase III randomized study of continuous REVLIMID in combination with dexamethasone in patients newly diagnosed with multiple myeloma who are not candidates for stem cell transplant - have been published in the New England Journal of Medicine. Initial findings, including that the trial had met its primary endpoint of progression free survival , were reported during the plenary session at the 55th American Society of Hematology annual meeting in December 2013.

    Comment?

  10. The more uncertain we are, the more careful we should beRead the original story

    Sunday Sep 7 | Resource Insights

    It is a staple of apologists for the chemical and fossil fuel industries to say, "We have no proof that what you are talking about is dangerous." Let me restate that in probabilistic terms: "We are highly uncertain about the harm of what you are talking about."

    Comment?

  11. Amputee Nick Newell is a champion fighterRead the original story w/Photo

    Saturday Sep 6 | The Star Online

    Nick Newell was born with congenital amputation of his left arm, but that hasn't stopped him from becoming a champion fighter. With just one fully developed arm, he has punched, battered and trashed his opponents to emerge victorious in the World Series of Fighting circuit's lightweight category.

    Comment?

  12. Deadly disease v untested treatmentRead the original story w/Photo

    Saturday Sep 6 | BBC News

    When faced with a deadly disease, such as Ebola, that has no known cure and kills half of those it infects, it's tempting to give any experimental treatment a try - no matter how risky. In recent weeks, doctors at the Royal Free Hospital in London have given William Pooley, the British nurse infected with Ebola, an experimental drug called ZMapp.

    Comment?

  13. Positive Phase III Results Reported for Lenalidomide Plus Dexamethasone in Multiple Myeloma PatientsRead the original story

    Friday Sep 5 | P&T Community

    Positive data have been reported from an open-label phase III randomized study of continuous lenalidomide in combination with dexamethasone in patients with newly diagnosed multiple myeloma who were not candidates for stem-cell transplant. In the FIRST trial, 1,623 patients ineligible for stem-cell transplant were randomly assigned to three treatment arms: lenalidomide plus low-dose dexamethasone in 28-day cycles until disease progression ; lenalidomide plus low-dose dexamethasone for 72 weeks ; or melphalan, prednisone, and thalidomide in 42-day cycles for 72 weeks .

    Comment?

  14. New myeloma treatment options show promiseRead the original story w/Photo

    Thursday Sep 4 | PhysOrg Weblog

    New multiple myeloma treatment options appear promising for patients aged 65 years and younger and for newly diagnosed patients who are ineligible for stem-cell transplantation, according to two studies published in the Sept. 4 issue of the New England Journal of Medicine .

    Comment?

  15. SLGA preps for FASD awareness dayRead the original story

    Wednesday Sep 3 | Yorkton This Week & Enterprise

    It can be debilitating, often causing lifelong mental and physical challenges, learning disabilities and behavioural problems. Its victims are over-represented in the justice and prison systems, often due to impaired impulse control.

    Comment?

  16. Phase III Trial Of REVLIMID In Newly Diagnosed Multiple MyelomaRead the original story

    Thursday Sep 4 | Scientific Blogging

    Data from FIRST , an open-label phase III randomized study of continuous REVLIMID in combination with dexamethasone in patients newly diagnosed with multiple myeloma who are not candidates for stem cell transplant, have been published. The initial findings, including that the trial had met its primary endpoint of progression free survival, were reported during the plenary session at the 55th American Society of Hematology annual meeting in December 2013.

    Comment?

  17. The International Myeloma Foundation Says Newly Published Study...Read the original story

    Thursday Sep 4 | Freshnews

    The International Myeloma Foundation says newly published data confirm REVLIMID plus low-dose dexamethasone improves survival and other measures of efficacy, compared to MPT , a standard of care for newly diagnosed multiple myeloma patients who are not eligible for a stem cell transplant. The study also demonstrates that continuing use of REVLIMID-dexamethasone instead of stopping after a fixed number of treatments provides further advantages in multiple measures including overall survival, progression-free survival, time to disease progression, overall response rate, and duration of response.

    Comment?

  18. The Says Newly Published Study Confirms Survival Advantage With...Read the original story

    Thursday Sep 4 | BioSpace

    The International Myeloma Foundation says newly published data confirm REVLIMIDA plus low-dose dexamethasone improves survival and other measures of efficacy, compared to MPT , a standard of care for newly diagnosed multiple myeloma patients who are not eligible for a stem cell transplant. The study also demonstrates that continuing use of REVLIMID-dexamethasone instead of stopping after a fixed number of treatments provides further advantages in multiple measures including overall survival, progression-free survival, time to disease progression, overall response rate, and duration of response.

    Comment?

  19. Phase III FIRSTa (MM-020/IFM 07-01) Trial of REVLIMIDA ...Read the original story w/Photo

    Thursday Sep 4 | Business Wire

    4 issue of the New England Journal of Medicine . Initial findings, including that the trial had met its primary endpoint of progression free survival , were reported during the plenary session at the 55th American Society of Hematology annual meeting in December 2013.

    Comment?

  20. Medical providers present other side to vaccine storyRead the original story w/Photo

    Wednesday Sep 3 | Homer News

    In the Point of View article entitled "Truth about vaccines not told" printed on the Homer News editorial page on Aug. 28, concern was raised about the risk of routine vaccination causing autism. Twenty-five percent of parents still have the erroneous belief that autism is caused by the measles vaccine. 2 comments